Pfizer : PFE

All Pfizer Articles

1490 Articles

Jon C. Ogg | Mar 15, 2014 at 10:18 AM EDT

Analysts’ Top Dow Jones Industrial Dividend Stocks To Buy

After a rocky week where the markets were concerned about everything from Russia, slowing Chinese growth and why Malaysia Airlines Flight 370…

Trey Thoelcke | Mar 14, 2014 at 8:50 AM EDT

Jefferies’ Cheapest Health Care Stocks to Buy

In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis,…

Paul Ausick | Mar 12, 2014 at 2:51 PM EDT

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Wikimedia CommonsShares of drug maker Pfizer Inc. (NYSE: PFE) were halted Wednesday afternoon at $32.29, down about 0.4% from the…

Paul Ausick | Mar 12, 2014 at 11:20 AM EDT

Short Interest Generally Wanes in High-Yield Dividend Stocks

ThinkstockThe short interest data for the final two weeks of February is out, and the results are somewhat surprising when…

Trey Thoelcke | Mar 10, 2014 at 9:05 AM EDT

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…

Paul Ausick | Mar 6, 2014 at 4:01 PM EST

The 4 Stocks That Dominated the Market on Thursday

thinkstockMarch 6, 2014: Markets opened higher on Thursday after an encouraging report on new claims for jobless benefits, an improvement…

Trey Thoelcke | Mar 4, 2014 at 8:50 AM EST

Merrill Lynch’s Top Health Care Stocks to Buy Now

Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…

Paul Ausick | Feb 5, 2014 at 4:14 PM EST

The 4 Stocks That Dominated the Market on Wednesday

thinkstockFebruary 5, 2014: Markets opened lower on Wednesday following the report from ADP that nonfarm payrolls had risen less than…

Paul Ausick | Feb 5, 2014 at 8:20 AM EST

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to…

Paul Ausick | Feb 4, 2014 at 4:13 PM EST

The 4 Stocks That Dominated the Market on Tuesday

thinkstockFebruary 4, 2014: Markets opened higher on Tuesday following a crushing on Monday that saw all three major indexes put…

Jon C. Ogg | Feb 4, 2014 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014.…

Jon C. Ogg | Jan 29, 2014 at 8:35 AM EST

Top Analyst Upgrades and Downgrades: American Airlines, EA, Teradata, VMware, Walmart and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, January 29, 2014.…

Paul Ausick | Jan 28, 2014 at 4:45 PM EST

The 4 Stocks That Dominated the Market on Tuesday

thinkstockJanuary 28, 2014: Markets opened mixed on Tuesday, with the Nasdaq trailing at the opening bell as shares in Apple…

Jon C. Ogg | Jan 28, 2014 at 7:30 AM EST

Pfizer Delivers on Earnings, Sets 2014 Guidance

Pfizer has managed to handily beat consensus fourth-quarter earnings expectations, at least on the surface. It also offered guidance for…

Douglas A. McIntyre | Jan 22, 2014 at 6:31 AM EST

Facebook Cements Position Among Most Traded Stocks

Facebook has been listed at a public company for two years, yet it is one of the most widely traded…

1 … 67 68 69 70 71 … 100

Pfizer : PFE

All Pfizer Articles

Analysts’ Top Dow Jones Industrial Dividend Stocks To Buy

Jefferies’ Cheapest Health Care Stocks to Buy

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Short Interest Generally Wanes in High-Yield Dividend Stocks

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

The 4 Stocks That Dominated the Market on Thursday

Merrill Lynch’s Top Health Care Stocks to Buy Now

The 4 Stocks That Dominated the Market on Wednesday

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

The 4 Stocks That Dominated the Market on Tuesday

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Top Analyst Upgrades and Downgrades: American Airlines, EA, Teradata, VMware, Walmart and More

The 4 Stocks That Dominated the Market on Tuesday

Pfizer Delivers on Earnings, Sets 2014 Guidance

Facebook Cements Position Among Most Traded Stocks

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

Pfizer : PFE

All Pfizer Articles

Analysts’ Top Dow Jones Industrial Dividend Stocks To Buy

Jefferies’ Cheapest Health Care Stocks to Buy

Pfizer Will Appeal Court Decision Regarding Celebrex Reissue Patent

Short Interest Generally Wanes in High-Yield Dividend Stocks

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

The 4 Stocks That Dominated the Market on Thursday

Merrill Lynch’s Top Health Care Stocks to Buy Now

The 4 Stocks That Dominated the Market on Wednesday

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

The 4 Stocks That Dominated the Market on Tuesday

Top Analyst Upgrades and Downgrades: Chevron, Gap, Merck, Microsoft, Zynga and More

Top Analyst Upgrades and Downgrades: American Airlines, EA, Teradata, VMware, Walmart and More

The 4 Stocks That Dominated the Market on Tuesday

Pfizer Delivers on Earnings, Sets 2014 Guidance

Facebook Cements Position Among Most Traded Stocks

Why Is Institutional Money Pouring Into XRP ETFs While Fleeing Bitcoin and Ethereum?

U.S. Interest Expense Just Hit $1.6 Trillion Annually. Peter Schiff Warns a Dollar Crisis Arrives When It Hits $2 Trillion.

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

Featured Reads

70-Year-Old Couple With $1.8M Just Got a Stage 2 Cancer Diagnosis. Financial Decisions They Have 60 Days to Make

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.